Some people with chronic obstructive pulmonary disease (COPD) need to use multiple inhaled medicines each day to control their symptoms. Long-acting combination inhalers that contain more than one ...
People with chronic obstructive pulmonary disease (COPD) often need to use many different inhalers every day to help them breathe better. But now, there are newer inhalers that combine different ...
Guiding people on how to correctly use inhaled medications via a phone-based program can help improve technique, according to a new study in the March 2026 issue of Chronic Obstructive Pulmonary ...
Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million Americans and is the fourth leading cause of death worldwide. Many people ...
If you have chronic obstructive pulmonary disease (COPD)-an umbrella term for several lung diseases, including emphysema, chronic bronchitis and some forms of asthmatic bronchitis-you know what a game ...
Please provide your email address to receive an email when new articles are posted on . Icenticaftor did not yield a dose response for trough FEV 1 at 12 weeks, but treatment was associated with ...
The first generic version of Symbicort -- a metered-dose inhaler that combines the corticosteroid budesonide with the long-acting bronchodilator formoterol -- has been approved for asthma and chronic ...
Millions of asthma, chronic bronchitis and emphysema sufferers can now begin ordering a Raleigh-based firm's new breath-activated devices for inhalers that are designed to improve drug delivery. While ...
Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for about three months, a new study has revealed. This research by The University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results